Tivic Health Systems
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 9
- Market Cap
- -
- Introduction
Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Fremont, CA.
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
ClearUP Longitudinal Pilot Study
- Conditions
- CongestionSinus Pain
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- Tivic Health Systems
- Target Recruit Count
- 30
- Registration Number
- NCT03888274
- Locations
- 🇺🇸
Allergy and Asthma Associates of Santa Clara Valley Research Center, San Jose, California, United States
A User Study of SYNUS Pain Relief Made by Tivic Health Systems
- Conditions
- Sinus; Inflammation
- First Posted Date
- 2018-03-15
- Last Posted Date
- 2018-12-26
- Lead Sponsor
- Tivic Health Systems
- Target Recruit Count
- 72
- Registration Number
- NCT03466879
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
News
Tivic Health Acquires Late-Stage Radiation Treatment Entolimod, Expanding into Immunotherapy
Tivic Health Systems has secured exclusive global rights to Entolimod, a Phase III TLR5 agonist from Statera Biopharma, for treating acute radiation syndrome.
Tivic Health Completes Enrollment in Vagus Nerve Stimulation Trial
Tivic Health has finished enrolling participants in a study evaluating its non-invasive vagus nerve stimulation (VNS) system.